The ROE as of December 2024 (TTM) for Kazia Therapeutics Limited (KZIA) is 661.24%

According to Kazia Therapeutics Limited’s latest financial reports and current stock price. The company's current ROE is 661.24%. This represents a change of -873.64% compared to the average of -85.47% of the last 4 quarters.

Kazia Therapeutics Limited (KZIA) Historical ROE (quarterly & annually)

How has KZIA ROE performed in the past?

The mean historical ROE of Kazia Therapeutics Limited over the last ten years is -34.26%. The current 661.24% ROE has changed -2029.85% with respect to the historical average. Over the past ten years (40 quarters), KZIA's ROE was at its highest in in the December 2017 quarter at 1.65%. The ROE was at its lowest in in the June 2014 quarter at -292.00%.

Kazia Therapeutics Limited (KZIA) ROE by Quarter and Year

Discovering the peaks and valleys of Kazia Therapeutics Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Kazia Therapeutics Limited (KZIA) Average ROE

How has KZIA ROE performed in the past?

The current ROE of Kazia Therapeutics Limited (KZIA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Kazia Therapeutics Limited (KZIA) ROE vs. Peers

How is KZIA’s ROE compared to its peers?

Kazia Therapeutics Limited’s ROE is greater than CytomX Therapeutics, Inc. (-41.34%), greater than Assembly Biosciences, Inc. (-121.46%), greater than Ocular Therapeutix, Inc. (-56.75%), greater than Spero Therapeutics, Inc. (3.36%), greater than Achilles Therapeutics plc (-54.57%), greater than SELLAS Life Sciences Group, Inc. (-629.45%), less than NLS Pharmaceutics AG (22.54%), greater than Mereo BioPharma Group plc (-69.11%), greater than Aravive, Inc. (-433.14%), greater than Day One Biopharmaceuticals, Inc. (-22.40%), less than ZIVO Bioscience, Inc. (618.61%), greater than RenovoRx, Inc. (-242.57%), greater than Pasithea Therapeutics Corp. (-81.66%), greater than Quoin Pharmaceuticals, Ltd. (-126.19%), greater than ARCA biopharma, Inc. (-20.18%), greater than Bionomics Limited (-116.12%), greater than OKYO Pharma Limited (0.42%), less than Candel Therapeutics, Inc. (3.21%), greater than Anebulo Pharmaceuticals, Inc. (-184.40%), greater than Cingulate Inc. (-113174.53%), greater than Nurix Therapeutics, Inc. (-63.39%), greater than Seer, Inc. (-22.19%), greater than Quantum-Si incorporated (-37.12%), greater than HCW Biologics Inc. (-2516.87%), greater than MediciNova, Inc. (-20.70%),

Build a custom stock screener for Kazia Therapeutics Limited (KZIA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kazia Therapeutics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kazia Therapeutics Limited (KZIA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kazia Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.